1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi: 10.1016/S0140-6736(08)60074-4.
2. Park GY, Park WS, Sung SI, Kim MS, Lee MH, Jeon GW, et al. Neonatal outcome comparisons between preterm infants with or without early pulmonary hypertension following prolonged preterm premature rupture of membranes before 25 gestational weeks in Korean Neonatal Network. J Matern Fetal Neonatal Med. 2020:1–24. doi: 10.1080/14767058.2020.1749590. PubMed PMID: 32228112.
3. Pendse A, Panchal H, Athalye-Jape G, Campbell C, Nathan E, Rao S, et al. Neonatal outcomes following previable prelabour rupture of membranes before 23 weeks of gestation- a retrospective cohort study. J Neonatal Perinatal Med. 2020. doi: 10.3233/NPM-190366. PubMed PMID: 32224534.
4. Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno AS, et al. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2018;46(5):465–88. doi: 10.1515/jpm-2017-0027. PubMed PMID: 28710882.
5. Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora P, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol. 1998;179(5):1248–53. PubMed PMID: 9822510.
6. Wang H, Ogawa M, Wood JR, Bartolomei MS, Sammel MD, Kusanovic JP, et al. Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet. 2008;17(8):1087–96. doi: 10.1093/hmg/ddm381. PubMed PMID: 18178580.
7. Romero R, Chaiworapongsa T, Espinoza J, Gomez R, Yoon BH, Edwin S, et al. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol. 2002;187(5):1125–30. PubMed PMID: 12439489.
8. Soylu H, Jefferies A, Diambomba Y, Windrim R, Shah PS. Rupture of membranes before the age of viability and birth after the age of viability: comparison of outcomes in a matched cohort study. J Perinatol. 2010;30(10):645–9. doi: 10.1038/jp.2010.11. PubMed PMID: 20220762.
9. Gomez R, Romero R, Nien JK, Medina L, Carstens M, Kim YM, et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med. 2007;20(2):167–73. doi: 10.1080/14767050601135485. PubMed PMID: 17437216.
10. Williams O, Michel B, Hutchings G, Debauche C, Hubinont C. Two-year neonatal outcome following PPROM prior to 25 weeks with a prolonged period of oligohydramnios. Early Hum Dev. 2012;88(8):657–61. doi: 10.1016/j.earlhumdev.2012.01.012. PubMed PMID: 22682720.
11. Muraskas J, Astrug L, Amin S. FIRS: Neonatal considerations. Semin Fetal Neonatal Med. 2020;25(4):101142. doi: 10.1016/j.siny.2020.101142. PubMed PMID: 32912755.
12. Tchirikov M, Zhumadilov Z, Winarno AS, Haase R, Buchmann J. Treatment of Preterm Premature Rupture of Membranes with Oligo-/Anhydramnion Colonized by Multiresistant Bacteria with Continuous Amnioinfusion and Antibiotic Administrations through a Subcutaneously Implanted Intrauterine Port System: A Case Report. Fetal Diagn Ther. 2015. doi: 10.1159/000438483. PubMed PMID: 26447923.
13. Tchirikov M, Bapayeva G, Zhumadilov ZS, Dridi Y, Harnisch R, Herrmann A. Treatment of PPROM with anhydramnion in humans: first experience with different amniotic fluid substitutes for continuous amnioinfusion through a subcutaneously implanted port system. J Perinat Med. 2013;41(6):657–63. doi: 10.1515/jpm-2012-0296. PubMed PMID: 23774012.
14. Ono T, Tsumura K, Kawasaki I, Ikeda M, Hideshima M, Tsuda S, et al. Continuous amnioinfusion for treatment of mid-trimester preterm premature rupture of membranes with oligoamnios. J Obstet Gynaecol Res. 2020;46(1):79–86. doi: 10.1111/jog.14151. PubMed PMID: 31650672.
15. Esaki M, Maseki Y, Tezuka A, Furuhashi M. Continuous amnioinfusion in women with PPROM at periviable gestational ages. J Matern Fetal Neonatal Med. 2020;33(7):1151–6. doi: 10.1080/14767058.2018.1517307. PubMed PMID: 30149736.
16. Locatelli A, Andreani M, Ghidini A, Verderio M, Pizzardi A, Vergani P, et al. Amnioinfusion in preterm PROM: effects on amnion and cord histology. J Perinatol. 2008;28(2):97–101. doi: 10.1038/sj.jp.7211876. PubMed PMID: 18046340.
17. Roberts D, Vause S, Martin W, Green P, Walkinshaw S, Bricker L, et al. Amnioinfusion in very early preterm prelabor rupture of membranes (AMIPROM): pregnancy, neonatal and maternal outcomes in a randomized controlled pilot study. Ultrasound Obstet Gynecol. 2014;43(5):490–9. doi: 10.1002/uog.13258. PubMed PMID: 24265189.
18. Roberts D, Vause S, Martin W, Green P, Walkinshaw S, Bricker L, et al. Amnioinfusion in preterm premature rupture of membranes (AMIPROM): a randomised controlled trial of amnioinfusion versus expectant management in very early preterm premature rupture of membranes--a pilot study. Health Technol Assess. 2014;18(21):1–135. doi: 10.3310/hta18210. PubMed PMID: 24713309.
19. Santis M de, Scavo M, Noia G, Masini L, Piersigilli F, Romagnoli C, et al. Transabdominal amnioinfusion treatment of severe oligohydramnios in preterm premature rupture of membranes at less than 26 gestational weeks. Fetal Diagn Ther. 2003;18(6):412–7. PubMed PMID: 14564111.
20. Tchirikov M, Oshovskyy V, Steetskamp J, Falkert A, Huber G, Entezami M. Neonatal outcome using ultrathin fetoscope for laser coagulation in twin-to-twin-transfusion syndrome. J Perinat Med. 2011;39(6):725–30. doi: 10.1515/JPM.2011.091. PubMed PMID: 21867454.
21. Tchirikov M, Steetskamp J, Hohmann M, Koelbl H. Long-term amnioinfusion through a subcutaneously implanted amniotic fluid replacement port system for treatment of PPROM in humans. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):30–3. doi: 10.1016/j.ejogrb.2010.04.023. PubMed PMID: 20488612.
22. Berger R, Abele H, Bahlmann F, Bedei I, Doubek K, Felderhoff-Müser U, et al. Prävention und Therapie der Frühgeburt. Leitlinie der DGGG, OEGGG und SGGG (S2k-Niveau, AWMF-Registernummer 015/025, Februar 2019) – Teil 2 mit Empfehlungen zur tertiären Prävention der Frühgeburt und zum Management des frühen vorzeitigen Blasensprungs. Z Geburtshilfe Neonatol. 2019;223(6):373–94. doi: 10.1055/a-1008-8730. PubMed PMID: 31801169.
23. Chen F, Bajwa NM, Rimensberger PC, Posfay-Barbe KM, Pfister RE. Thirteen-year mortality and morbidity in preterm infants in Switzerland. Arch Dis Child Fetal Neonatal Ed. 2016;101(5):F377-83. doi: 10.1136/archdischild-2015-308579. PubMed PMID: 27059074.
24. Crane JMG, Magee LA, Lee T, Synnes A, Dadelszen P von, Dahlgren L, et al. Maternal and perinatal outcomes of pregnancies delivered at 23 weeks' gestation. J Obstet Gynaecol Can. 2015;37(3):214–24. PubMed PMID: 26001868.
25. Burri PH. Fetal and postnatal development of the lung. Annu Rev Physiol. 1984;46:617–28. doi: 10.1146/annurev.ph.46.030184.003153. PubMed PMID: 6370120.
26. Manuck TA, Varner MW. Neonatal and early childhood outcomes following early vs later preterm premature rupture of membranes. Am J Obstet Gynecol. 2014;211(3):308.e1-6. doi: 10.1016/j.ajog.2014.05.030. PubMed PMID: 24858202.
27. The royal womens hospital. Rupture of the Membranes - Preterm Premature (PPROM): Policy, Guideline and Procedure Manual [cited 2016 Dec 11]. Available from: https://thewomens.r.worldssl.net/images/uploads/downloadable-records/clinical-guidelines/rupture-of-membranes-preterm-premature-pprom.pdf.
28. Romero R, Miranda J, Chaemsaithong P, Chaiworapongsa T, Kusanovic JP, Dong Z, et al. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2015;28(12):1394–409. doi: 10.3109/14767058.2014.958463. PubMed PMID: 25190175.
29. Romero R, Friel LA, Velez Edwards DR, Kusanovic JP, Hassan SS, Mazaki-Tovi S, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol. 2010;203(4):361.e1-361.e30. doi: 10.1016/j.ajog.2010.05.026. PubMed PMID: 20673868.
30. Joyce EM, Moore JJ, Sacks MS. Biomechanics of the fetal membrane prior to mechanical failure: review and implications. Eur J Obstet Gynecol Reprod Biol. 2009;144 Suppl 1:S121-7. doi: 10.1016/j.ejogrb.2009.02.014. PubMed PMID: 19303191.
31. Helmig BR, Romero R, Espinoza J, Chaiworapongsa T, Bujold E, Gomez R, et al. Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med. 2002;12(4):237–46. doi: 10.1080/jmf.12.4.237.246. PubMed PMID: 12572592.
32. George RB, Kalich J, Yonish B, Murtha AP. Apoptosis in the chorion of fetal membranes in preterm premature rupture of membranes. Am J Perinatol. 2008;25(1):29–32. doi: 10.1055/s-2007-1004828. PubMed PMID: 18075963.
33. Dutta EH, Behnia F, Boldogh I, Saade GR, Taylor BD, Kacerovsky M, et al. Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes. Mol Hum Reprod. 2016;22(2):143–57. doi: 10.1093/molehr/gav074. PubMed PMID: 26690900.
34. Beckmann MW, Wiegratz I, Dereser MM, Baier P, Born HJ. Diagnostik des Blasensprungs: Vergleich des vaginalen Nachweises von fetalem Fibronectin und der intraamnialen Injektion von Indigo Carmine. Geburtshilfe Frauenheilk. 1993;53(2):86–91. doi: 10.1055/s-2007-1023643. PubMed PMID: 8462836.
35. Sosa CG, Herrera E, Restrepo JC, Strauss A, Alonso J. Comparison of placental alpha microglobulin-1 in vaginal fluid with intra-amniotic injection of indigo carmine for the diagnosis of rupture of membranes. J Perinat Med. 2014;42(5):611–6. doi: 10.1515/jpm-2013-0245. PubMed PMID: 24698819.
36. Pristauz G, Bauer M, Maurer-Fellbaum U, Rotky-Fast C, Bader AA, Haas J, et al. Neonatal outcome and two-year follow-up after expectant management of second trimester rupture of membranes. Int J Gynaecol Obstet. 2008;101(3):264–8. doi: 10.1016/j.ijgo.2007.12.007. PubMed PMID: 18289539.
37. Benirschke K, Burton GJ, Baergen RN. Pathology of the Human Placenta. 6th ed. Berlin, Heidelberg: Springer Berlin Heidelberg; 2012.
38. Polachek H, Holcberg G, Sapir G, Tsadkin-Tamir M, Polachek J, Katz M, et al. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro. Eur J Obstet Gynecol Reprod Biol. 2005;122(1):61–5. doi: 10.1016/j.ejogrb.2004.11.031. PubMed PMID: 16154040.
39. Park HS, Ahn B-J, Jun JK. Placental transfer of clarithromycin in human pregnancies with preterm premature rupture of membranes. J Perinat Med. 2012;40(6):641–6. doi: 10.1515/jpm-2012-0038. PubMed PMID: 23095192.
40. Onwuchuruba CN, Towers CV, Howard BC, Hennessy MD, Wolfe L, Brown MS. Transplacental passage of vancomycin from mother to neonate. Am J Obstet Gynecol. 2014;210(4):352.e1-4. doi: 10.1016/j.ajog.2014.01.019. PubMed PMID: 24679944.
41. Muller AE, Oostvogel PM, DeJongh J, Mouton JW, Steegers EAP, Dorr PJ, et al. Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera. Antimicrob Agents Chemother. 2009;53(4):1574–80. doi: 10.1128/AAC.00119-08. PubMed PMID: 19164154.
42. Hnat M, Bawdon RE. Transfer of meropenem in the ex vivo human placenta perfusion model. Infect Dis Obstet Gynecol. 2005;13(4):223–7. doi: 10.1080/10647440500147992. PubMed PMID: 16338783.
43. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG. 2000;107(6):770–5. PubMed PMID: 10847234.
44. Meeraus WH, Petersen I, Gilbert R. Association between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the health improvement network. PLoS One. 2015;10(3):e0122034. doi: 10.1371/journal.pone.0122034. PubMed PMID: 25807115.
45. Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol. 2005;25(5):341–8. doi: 10.1038/sj.jp.7211290. PubMed PMID: 15861199.
46. Gilbert WM, Brace RA. Amniotic fluid volume and normal flows to and from the amniotic cavity. Semin Perinatol. 1993;17(3):150–7. PubMed PMID: 8378799.
47. Shields LE, Moore TR, Brace RA. Fetal electrolyte and acid-base responses to amnioinfusion: lactated Ringer's versus normal saline in the ovine fetus. J Soc Gynecol Investig. 1995;2(4):602–8. PubMed PMID: 9420864.
48. Fitzsimmons ED, Bajaj T. StatPearls: Embryology, Amniotic Fluid. Treasure Island (FL); 2020.
49. Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol. 2000;13(6):691–7. doi: 10.1097/00019052-200012000-00014. PubMed PMID: 11148672.
50. Chhabra A, Kaushik R, Kaushik RM, Goel D. Extra-pontine myelinolysis secondary to hypernatremia induced by postpartum water restriction. Neuroradiol J. 2017;30(1):84–7. doi: 10.1177/1971400916678246. PubMed PMID: 28059675.